CVS Says New Cholesterol Drug Types Could Be Costly By: Benzinga via Benzinga March 20, 2015 at 12:58 PM EDT A new type of cholesterol drug in development by Amgen, Inc. (NASDAQ: AMGN) and another by Sanofi SA (ADR) (NYSE: SNY) with Regeneron ... Read More >> Related Stocks: Amgen CVS Health Corp Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR